Elsubrutinib (ABBV-105) is an orally active, potent, selective and irreversible Brutons tyrosine kinase (BTK) inhibitor. The IC50 of Elsubrutinib for BTK catalytic domain is 0.18 µM. Elsubrutinib can be used for the research of inflammatory disease[1].
Molecular Weight:
297.35
Purity:
98
CAS Number:
[1643570-24-4]
Formula:
C17H19N3O2
Target:
Btk
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
